COVID-19 Vaccines: AstraZeneca Resumes Trial; Pfizer, BioNTech Look to Expand Study
AstraZeneca has resumed a phase 3 clinical trial investigating AZD1222, its COVID-19 vaccine candidate.
Vaccines
FDA May Approve COVID-19 Vaccines Before Clinical Trials Completion
Emergency use authorization or approval for a COVID-19 vaccine before phase 3 clinical trials are complete could be considered by the US FDA.
ACIP Issues Recommendations for 2020 to 2021 Flu Vaccination
ACIP recommendations have been updated to include the influenza vaccination for the 2020 to 2021 season.
HHS Authorizes Pharmacists to Administer Vaccines to Children
HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
HBV Screening Beneficial in Immunocompromised Pediatric Patients With Rheumatologic Conditions and IBD
Researchers evaluated the prevalence of serologic immunity against hepatitis B virus in immunocompromised patients with pediatric-onset inflammatory bowel disease and rheumatologic diseases.
FDA Head Says Any Approved COVID-19 Vaccine Will Be Safe
The US FDA announced it will not compromise safety when approving a COVID-19 vaccine.
Novavax’s Adjuvanted COVID-19 Vaccine Candidate Shows Promise in Early Trial
Novavax announced positive phase 1 data of its COVID-19 vaccine candidate, NVX-CoV2373.
Phase 3 Trial of COVID-19 Vaccine Candidate mRNA-1273 Begins
Phase 3 trial initiated evaluating the vaccine candidate mRNA-1273 against COVID-19.
Ad5-Vectored COVID-19 Vaccine Immunogenic in Healthy Adults
The nonreplicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine appears safe and induces immune responses.
Pfizer, BioNTech Sign Deal for 100 Million COVID-19 Vaccine Doses
The US Department of Health and Human Services and the Department of Defense have agreed to receive 100 million doses of BNT162, a vaccine for SARS-CoV-2, once the manufacturers obtains approval or emergency use authorization (EUA) from the FDA
-
Loading...
-
Loading...
Next post in Practice Management
